株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

医療市場調査レビュー:2015年

2015 Healthcare Research Review

発行 BCC Research 商品コード 227024
出版日 ページ情報 英文 182 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.77円で換算しております。

2016年12月31日まで 年末キャンペーン割引: BCC Research社発行レポート
ご注意: ショッピングカートでは適用されませんので、割引価格についてはお問い合わせください

Back to Top
医療市場調査レビュー:2015年 2015 Healthcare Research Review
出版日: 2016年01月11日 ページ情報: 英文 182 Pages
担当者のコメント
BCC Research社のレポートは、Reuter、Wall Street Journal、Fortuneなどで引用されることも多く、それぞれの業界の識者の意見として重きを置かれています。同社レポートを複数冊ご購入の場合年間パッケージのご契約がお得です。詳細は右の担当者のおすすめ商品よりご覧下さい。
概要

米国の薬事未承認検査 (LDT:Laboratory Developed Test) の市場は2014年から2019年にかけて12.7%のCAGRで推移し、2014年の97億ドルから、2019年には177億ドルに近い規模に成長すると予測されています。

当レポートでは、BBCC Researchが2015年に出版したレポートから特定の調査カテゴリーのレポートを選定し (LDT・放射線治療・最小侵襲性医療機器・使い捨て医療用センサー・健康状態のセルフモニタリング・眼用装具)、各種技術の現状と開発動向、関連法規制およびその他の市場影響因子の分析、今後の市場の展望などを抜粋し、まとめています。

第1章 はじめに

第2章 薬事未承認検査 (LDT:Laboratory Developed Test) の各種技術と市場 (REPORT HLC179A)

  • イントロダクション
  • サマリー
  • 主要動向
    • FDAによる規制の台頭
    • ゲノム的強化
    • 学術医療センターの衰退
    • LDTの進化
    • 分子診断の爆発的発展
    • ライセンシング&新興企業への投資へのシフト
    • 血清学の緩やかな衰退
  • LDTの概要
  • 臨床診断試験のライフサイクル
  • LDT利用の理由
  • 一般的技術
    • PCR
    • 次世代シーケンシング
    • その他の分子技術
    • 質量分析
    • HPLC-MS
    • MALDI-TOF
    • イムノアッセイ
  • 適応症
    • 感染症
    • 希少疾患
    • 産科
    • 慢性疾患
  • LDTとFDA承認検査の違い

第3章 放射線治療の各種技術と世界市場 (REPORT HLC176A)

  • イントロダクション
  • エグゼクティブサマリー
  • 市場概要
  • 癌について
    • 良性腫瘍
    • 悪性腫瘍
    • その他のタイプの癌
    • 癌の原因
    • 防御因子・リスク因子
    • 放射線について
    • 放射線治療の経緯
  • 作用機序
    • 細胞増殖サイクル
  • 放射線治療におけるリスク管理・品質保証
    • 放射線治療市場の区分
    • 推進因子・障壁・市場機会・各種動向
  • 推進因子
  • 障壁
  • 市場機会
  • 各種動向
    • VMAT
    • 脅威
    • 市場シェア分析
    • さまざまな癌治療
    • SRS・分割定位放射線治療

第4章 最小侵襲性医療機器の市場 (REPORT HLC051G)

  • 最小侵襲手術
  • イントロダクション
  • エグゼクティブサマリー
  • 一般的概要
  • HISTORY OF 最小侵襲手術
    • 内視鏡
    • ガス注入
    • 特殊外科器具
    • 最小侵襲手術手順
    • 手術ロボット
    • 医療レーザー
    • 外科の各種動向・最小侵襲手術の重要性の増大
    • 最小侵襲手術の主な対象
    • 胃腸手術
    • 婦人科
    • 泌尿器科
    • 美容外科
    • 胸部外科
    • 心胸外科
    • 非心胸血管介入手術
    • 整形外科
  • 製品タイプ
    • モニタリング/可視化装置
    • ロボット支援手術システム
    • 電気手術器具
    • 機械器具
    • 補助設備
    • 外科器具
    • MIS用器具の法規制上の位置付け
    • 医学部

第5章 使い捨て医療用センサーの各種技術と世界市場 (REPORT HLC182A)

  • イントロダクション
  • エグゼクティブサマリー
  • 市場概要
  • センサーの各種タイプ
  • 市場区分
    • 主要市場動向
  • 市場力学
    • 推進因子
    • 障壁
    • 市場機会
  • 市場戦略
    • R&Dへの投資の拡大
    • 競合環境
  • 法規制
    • 米国
    • EU
    • 中国
  • 技術革新
    • タトゥー型センサー
    • パッチセンサー
    • スリープストリップ
    • 癌追跡埋め込みセンサー
    • 使い捨てHBA1Cセンサー
    • MEMS圧力センサー
    • NEMS:将来の技術
    • 革新的使い捨てセンサー
  • 現在の動向
  • 使い捨て無線センサーの製造業者のメリット
  • 使い捨て医療用センサー市場の成長の見通し

第6章 健康状態のセルフモニタリングの各種技術と世界市場 (REPORT HLC185A)

  • イントロダクション
  • エグゼクティブサマリー
  • 定義
    • デジタル VS アナログモニタリング技術
    • モバイル VS ポータブルモニタリング技術
    • セルフテスト VS セルフモニタリング
    • 健康状態 VS スポーツ&フィットネスモニタリング
  • 実現技術
    • スマートフォン
    • 強化型データ処理能力
    • センサー
    • 地球空間的トラッキング
    • ウェアラブルセンサー用スマートテキスタイル
    • ネットワーキング技術
    • クラウドサービス
  • 市場区分
    • 技術
    • 用途
    • 購入者/支払い者
    • 市場サマリー

第7章 眼用装具の各種技術と世界市場 (REPORT HLC173A)

  • イントロダクション
  • サマリー
  • ヒトの眼について
  • 目の症状・対象人口
    • 白内障
    • 緑内障
    • 糖尿病性網膜症
    • 加齢黄斑変性症
    • 反射機能障害

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: HLC068F

REPORT HIGHLIGHTS

  • The laboratory-developed test market within the U.S. is expected to grow from $9.7 billion in 2014 to nearly $17.7 billion in 2019, a compound annual growth rate (CAGR) of 12.7% from 2014 to 2019.
  • The radiation therapy market totaled $5.8 billion in 2014 and is expected to reach $8.1 billion in 2019, with a CAGR of 6.7%.
  • The global market for minimally invasive medical devices and equipment reached roughly $15.4 billion in 2014 and is expected to reach $21.5 billion in 2019, registering a CAGR of 6.8% for the period 2014-2019.

REPORT SCOPE

Research Reviews from BCC Research provide market professionals with concise market coverage within a specific research category. These Research Reviews include portions of several market research reports that were published in 2015, and are an efficient way for market professionals to keep up with the general market developments of 2015.

Please note that page references in the text are to pages in the original, complete report, and do not reflect the actual page numbers in this Research Review.

Table of Contents

CHAPTER 1 - FOREWORD

CHAPTER 2 - LABORATORY-DEVELOPED TESTING: TECHNOLOGIES AND MARKETS (REPORT HLC179A)

  • INTRODUCTION
    • STUDY GOALS AND OBJECTIVES
    • REASONS FOR DOING THE STUDY
    • SCOPE OF REPORT
    • INTENDED AUDIENCE
    • INFORMATION SOURCES
    • ANALYST'S CREDENTIALS
    • RELATED BCC RESEARCH REPORTS
  • SUMMARY
    • TABLE 1 MARKET FOR U.S. LABORATORY-DEVELOPED TESTS, THROUGH 2019 ($ MILLIONS)
    • FIGURE 1 MARKET FOR U.S. LABORATORY-DEVELOPED TESTS, 2012-2019 ($ MILLIONS)
  • KEY TRENDS
    • THE RISE OF FDA REGULATION
    • GENOMIC RAMP-UP
    • DECLINE OF THE ACADEMIC MEDICAL CENTER
    • EVOLUTION OF THE LABORATORY-DEVELOPED TEST (LDT)
    • MOLECULAR DIAGNOSTICS EXPLOSION
    • SHIFTS TOWARD LICENSING AND STARTUP INVESTMENT
    • SLOW DECLINE OF SEROLOGY
  • OVERVIEW: DESCRIPTION OF LABORATORY-DEVELOPED TESTS
  • LIFE CYCLE OF CLINICAL DIAGNOSTIC TESTS
    • TABLE 2 LIFE CYCLE OF CLINICAL DIAGNOSTIC TESTS
  • WHY USE AN LDT
  • COMMON TECHNOLOGIES USED
    • POLYMERASE CHAIN REACTION (PCR)
      • How PCR Works in an LDT
    • NEXT-GENERATION SEQUENCING
      • How NGS Works in LDTs
        • Sequencing by Synthesis
        • Solid Sequencing
        • Semiconductor Sequencing
    • OTHER MOLECULAR TECHNOLOGIES
    • MASS SPECTROMETRY
      • How Mass Spectrophotometry Works in LDTs
    • HPLC-MS
    • MALDI-TOF
    • IMMUNOASSAYS
      • How an Immunoassay Works in an LDT
  • CLINICAL INDICATIONS
    • ONCOLOGY
    • INFECTIOUS DISEASE
    • RARE DISEASES
    • MATERNITY
    • CHRONIC DISEASE
  • DIFFERENCES BETWEEN LDTS AND FDA APPROVED TESTS

CHAPTER 3 - RADIOTHERAPY: TECHNOLOGIES AND GLOBAL MARKETS (REPORT HLC176A)

  • INTRODUCTION
    • STUDY GOALS AND OBJECTIVES
    • REASONS FOR DOING THE STUDY
    • SCOPE OF REPORT
    • INTENDED AUDIENCE
    • RESEARCH METHODOLOGY
    • ANALYST'S CREDENTIALS
    • RELATED BCC RESEARCH REPORTS
  • EXECUTIVE SUMMARY
    • TABLE 3 RADIATION THERAPY MARKET BY TYPE, THROUGH 2019 ($ MILLIONS)
    • FIGURE 2 RADIATION THERAPY MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
  • MARKET OVERVIEW
  • INTRODUCTION TO CANCER
    • BENIGN TUMORS
    • MALIGNANT TUMORS
      • Malignant Tumor Categories
        • Carcinomas
        • Sarcomas
    • OTHER TYPES OF CANCER
      • TABLE 4 CHARACTERISTICS OF BENIGN AND MALIGNANT TUMORS
    • CAUSES OF CANCER
      • Internal Factors
      • External Factors
    • CANCER PROTECTIVE FACTORS AND RISK FACTORS
      • TABLE 5 IMPACT OF CANCER PROTECTIVE FACTORS AND CANCER RISK FACTORS ON VARIOUS TYPES OF CANCERS
    • INTRODUCTION TO RADIATION
      • FIGURE 3 TYPES OF RADIATION
      • NON-IONIZING RADIATION
      • IONIZING RADIATION
      • PARTICLE RADIATION
        • Electron Beams
        • Proton Beams
        • Neutron Beams
        • Carbon Ions
        • Alpha and Beta Particles
        • Photon Radiations
        • Gamma Rays
        • X-rays
    • HISTORY OF RADIATION THERAPY
      • The Discovery Period
      • Megavoltage Era (1946-1996)
      • Computer-Assisted ERA (1996-2013)
  • MECHANISM OF ACTION
    • CELL GROWTH CYCLE
      • FIGURE 4 CELL GROWTH CYCLE
      • TABLE 6 STEPS INVOLVED IN RADIATION THERAPY
  • RISK MANAGEMENT AND QUALITY ASSURANCE IN RADIATION THERAPY
    • RADIATION THERAPY MARKET SEGMENTATION
      • FIGURE 5 RADIATION THERAPY MARKET SEGMENTATION
    • DRIVERS, RESTRAINTS, OPPORTUNITIES AND TRENDS
      • FIGURE 6 DRIVERS, RESTRAINTS, OPPORTUNITIES AND TRENDS IN THE RADIATION THERAPY MARKET
  • DRIVERS
    • Increasing Incidences of Cancer
    • High Incidence of Cancer in Aging Population
      • FIGURE 7 GLOBAL AGING POPULATION (MILLIONS)
      • FIGURE 8 FACTORS RELATED TO AGING AND THE PROMOTION OF CANCER
    • High Efficiency of Radiotherapy
    • Palliative Radiation Therapy
    • Government Funding
    • Advancement in Technology
    • Reimbursement Boosting Market Growth
  • RESTRAINTS
    • Capital Intensive
    • Lack of Trained Professionals
    • Limited Effectiveness against Metastatic Cancer
    • Side Effects Associated with Radiation Therapy
  • OPPORTUNITY
    • Developing Countries
    • Personalized Treatment
  • TRENDS
    • VMAT
      • Proton Therapy
      • Carbon Ions
    • THREAT
      • Recession Could Restrict the Growth of Radiation Therapy Market
    • MARKET SHARE ANALYSIS
      • FIGURE 9 MARKET SHARE ANALYSIS OF THE RADIATION THERAPY MARKET, 2013 (%)
    • VARIOUS CANCER TREATMENTS
      • TABLE 7 ADVANTAGES AND DISADVANTAGES OF VARIOUS CANCER TREATMENTS
    • STEREOTACTIC RADIOSURGERY (SRS) AND FRACTIONATED STEREOTACTIC RADIATION THERAPY

CHAPTER 4 - THE MARKET FOR MINIMALLY INVASIVE MEDICAL DEVICES (REPORT HLC051G)

  • MINIMALLY INVASIVE SURGERY
    • MINIMALLY INVASIVE SURGERY VERSUS AMBULATORY SURGERY
    • MINIMALLY INVASIVE SURGERY VERSUS NONINVASIVE SURGERY
  • INTRODUCTION
    • STUDY BACKGROUND
    • STUDY GOALS AND OBJECTIVES
    • INTENDED AUDIENCE
    • SCOPE AND FORMAT OF REPORT
    • METHODOLOGY AND INFORMATION SOURCES
    • ANALYST'S CREDENTIALS
    • RELATED BCC RESEARCH REPORTS
  • EXECUTIVE SUMMARY
    • TABLE 8 GLOBAL MARKET FOR MIS DEVICES AND EQUIPMENT, THROUGH 2019 ($ MILLIONS)
    • FIGURE 10 GLOBAL MARKET FOR MIS DEVICES AND EQUIPMENT, 2013-2019 ($ MILLIONS)
  • GENERAL DESCRIPTION
  • HISTORY OF MINIMALLY INVASIVE SURGERY
    • ENDOSCOPY
    • INSUFFLATION
    • SPECIALIZED SURGICAL INSTRUMENTS
    • MINIMALLY INVASIVE SURGICAL PROCEDURES
    • SURGICAL ROBOTICS
    • MEDICAL LASERS
    • SURGICAL TRENDS AND THE GROWING IMPORTANCE OF MINIMALLY INVASIVE SURGERY
      • FIGURE 11 MIS PROCEDURES AS A PERCENTAGE OF ALL SURGICAL PROCEDURES PERFORMED IN THE U.S., 2013 (%)
      • FIGURE 12 MIS PROCEDURES AS A PERCENTAGE OF SELECTED TYPES OF SURGICAL MEASURES IN THE U.S., 2013
    • PRINCIPAL APPLICATIONS OF MINIMALLY INVASIVE SURGERY
      • FIGURE 13 SURGICAL PROCEDURES PERFORMED IN THE U.S. USING ALL MIS APPROACHES, 2013 (% OF ALL MIS PROCEDURES)
      • TABLE 9 SURGICAL PROCEDURES COMMONLY PERFORMED IN THE U.S. USING A MINIMALLY INVASIVE APPROACH, 2013
    • GASTROINTESTINAL SURGERY
      • Gallbladder Removal (Cholecystectomy)
      • Nissen Fundoplication
      • Adhesiolysis (Removal of Abdominal Scar Tissue)
      • Gastric Bypass
      • Appendectomy
      • Colon Resection
      • Hernia Repair
    • GYNECOLOGY
      • Hysterectomy
      • Myomectomy
      • Endometrial Ablation
      • Pelvic Floor Reconstruction
      • Adnexectomy (Removal of Adnexal Structures)
    • UROLOGY
      • Nephrectomy
      • Cystocele/Rectocele Repair
      • Pediatric Urology
      • Adrenalectomy
      • Radical Prostatectomy
    • COSMETIC SURGERY
      • Breast Augmentation
      • Face and Forehead Lifts
    • THORACIC SURGERY
      • Lung Biopsy
      • Lung Resection
      • Endoscopic Thoracic Sympathectomy
    • CARDIOTHORACIC SURGERY
      • Angioplasty and Other Catheterization Types
      • Coronary Artery Bypass
      • Heart Valve Repair and Replacement
      • Congenital Heart Defect Surgery
    • NONCARDIAC VASCULAR INTERVENTIONAL SURGERY
      • Saphenous Vein Harvest
      • Peripheral Vascular Bypass
      • Aortoiliofemoral Bypass
      • Abdominal Aortic Aneurism Repair
      • Lower Extremity Angioplasty
    • ORTHOPEDIC SURGERY
      • Joint Surgery
      • Arthroscopic Surgery
      • Arthroplasty
      • Damaged or Diseased Spinal Disk Surgery
      • Microendoscopic Diskectomy
      • Intradiskal Electrothermal Annuloplasty
      • Vertebroplasty and Kyphoplasty
  • PRODUCT TYPES
    • MONITORING/VISUALIZATION EQUIPMENT
      • TABLE 10 PRINCIPAL TYPES OF MONITORING/VISUALIZATION EQUIPMENT
    • ROBOTICALLY ASSISTED SURGICAL SYSTEMS
      • TABLE 11 PRINCIPAL TYPES OF SURGICAL ROBOTIC SYSTEMS
    • ELECTROSURGICAL EQUIPMENT
      • TABLE 12 ELECTROSURGICAL EQUIPMENT
    • MECHANICAL INSTRUMENTS
      • TABLE 13 PRINCIPAL TYPES OF MECHANICAL INSTRUMENTS
    • AUXILIARY EQUIPMENT
      • TABLE 14 PRINCIPAL TYPES OF AUXILIARY EQUIPMENT USED FOR MINIMALLY INVASIVE SURGERY
    • SURGICAL DEVICES
      • TABLE 15 MINIMALLY INVASIVE SURGICAL DEVICES
    • REGULATORY STATUS OF MIS EQUIPMENT
      • UNITED STATES
      • EUROPEAN UNION (EU)
      • JAPAN
      • OTHER COUNTRIES
        • Canada
        • China
        • India
        • Latin American Nations
        • Saudi Arabia
      • END-USER SEGMENTS
      • HOSPITAL SURGICAL DEPARTMENTS
        • FIGURE 14 U.S. HOSPITALS WITH SURGERY DEPARTMENTS, 2013 (NUMBER OF HOSPITALS)
      • OUTPATIENT SURGERY CENTERS
      • GROUP PRACTICES
      • INDIVIDUAL SURGEONS
        • FIGURE 15 U.S. SURGICAL SPECIALTIES, 2013 (% OF ALL U.S. SURGEONS)
    • MEDICAL SCHOOLS

CHAPTER 5 - DISPOSABLE MEDICAL SENSORS: TECHNOLOGIES AND GLOBAL MARKETS (REPORT HLC182A)

  • INTRODUCTION
    • STUDY OBJECTIVES
    • SCOPE OF THE REPORT
    • MARKET STRUCTURE
    • INTENDED AUDIENCE
    • RESEARCH METHODOLOGY
    • ANALYST'S CREDENTIALS
    • RELATED BCC RESEARCH REPORTS
  • EXECUTIVE SUMMARY
    • TABLE 16 GLOBAL MARKET FOR DISPOSABLE MEDICAL SENSORS BY REGION, THROUGH 2019 ($ MILLIONS)
    • FIGURE 16 GLOBAL MARKET FOR DISPOSABLE MEDICAL SENSORS BY REGION, 2013-2019 ($ MILLIONS)
  • MARKET OVERVIEW
    • TABLE 17 EVOLUTION OF MEMS IN THE HEALTHCARE SECTOR
  • TYPES OF SENSORS
    • FIGURE 17 TYPES OF SENSORS
  • MARKET SEGMENTATION
    • KEY MARKET TRENDS
      • FIGURE 18 SEGMENTATION OF BIOSENSORS
      • FIGURE 19 GLOBAL MARKET FOR DISPOSABLE MEDICAL SENSORS BY PRODUCT, 2013 ($ MILLIONS)
      • FIGURE 20 GLOBAL MARKET FOR DISPOSABLE MEDICAL SENSORS BY TYPE, 2013 ($ MILLIONS)
      • FIGURE 21 GLOBAL MARKET FOR DISPOSABLE MEDICAL SENSORS BY APPLICATION, 2013 ($ MILLIONS)
      • FIGURE 22 GLOBAL MARKET FOR DISPOSABLE MEDICAL SENSORS BY REGION, 2013-2019 ($ MILLIONS)
  • MARKET DYNAMICS
    • DRIVERS
      • Growing Number of People Affected by Target Diseases
      • Cardiovascular Diseases
      • Cancer
        • TABLE 18 CANCER INCIDENCES, 2008 AND 2015 (MILLIONS)
      • Diabetes
        • FIGURE 23 DIABETES PREVALENCE IN TOP 10 COUNTRIES FOR AGES 20 TO YEARS, 2013 (MILLIONS)
        • FIGURE 24 GLOBAL DIABETES PREVALENCE BY REGION, 2013 AND 2035 (MILLIONS)
        • TABLE 19 NORTH AMERICA DIABETES PREVALENCE BY COUNTRY, 2013 AND 2035 (%)
        • TABLE 20 EUROPEAN DIABETES PREVALENCE BY COUNTRY, 2013 AND 2035 (%)
        • TABLE 21 ASIA-PACIFIC DIABETES PREVALENCE BY COUNTRY, 2013 AND 2035 (%)
        • TABLE 22 LATIN AMERICAN DIABETES PREVALENCE BY COUNTRY, 2013 AND 2035 (%)
        • TABLE 23 MENA DIABETES PREVALENCE BY COUNTRY, 2013 AND 2035 (%)
        • TABLE 24 CIS DIABETES PREVALENCE BY COUNTRY, 2013 AND 2035 (%)
      • Deafness and Hearing Loss Disorders
        • FIGURE 25 ESTIMATED PERCENTAGE INCREASE IN NUMBER OF PERSONS (65 YEARS AND OLDER) WITH HEARING LOSS BY REGION, 2010-2020 (%)
      • Kidney Diseases
      • Chronic Pulmonary Diseases
      • Increasing Life Expectancy Triggering Incidence Rates of Target Diseases
        • FIGURE 26 GLOBAL PERCENTAGE A PERSON'S SUSCEPTIBILITY TO CHRONIC DISEASES BY AGE GROUP, 2000 AND 2015 (%)
    • RESTRAINTS
      • Lack of Standardization for Testing, Stringent Regulations and Reimbursement Policies for MEMS-based Sensors
    • OPPORTUNITIES
      • Technological Advances in MEMS Technology
      • Implantable MEMS-Based Sensors
        • TABLE 25 IMPLANTABLE SENSORS
  • MARKET STRATEGIES
    • INCREASE INVESTMENTS IN R&D
      • Opportunities in Emerging Economies
      • High Investment Costs Associated with MEMS-Based Devices
    • COMPETITIVE LANDSCAPE
      • FIGURE 27 GLOBAL MARKET SHARE FOR DISPOSABLE MEDICAL SENSORS BY COMPANY, 2013* (%)
  • REGULATIONS
    • UNITED STATES
    • EUROPEAN UNION
    • CHINA
      • FIGURE 28 APPROVAL PROCESS OF CHINA SFDA REGULATORY BODY INVOLVED IN DISPOSABLE MEDICAL SENSORS
  • INNOVATIONS IN TECHNOLOGY
    • TATTOO SENSORS
    • PATCH SENSORS
    • SLEEP STRIPS
    • CANCER-TRACKING IMPLANTABLE SENSORS
    • DISPOSABLE HBA1C SENSORS
    • MEMS PRESSURE SENSORS
    • NANOELECTROMECHANICAL SYSTEMS (NEMS): A FUTURE TECHNOLOGY
    • INNOVATIVE DISPOSABLE SENSORS
  • CURRENT TRENDS
  • ADVANTAGE TO MANUFACTURERS OF DISPOSABLE WIRELESS SENSORS
  • DISPOSABLE MEDICAL SENSORS MARKET SET TO GROW

CHAPTER 6 - HEALTH SELF-MONITORING: TECHNOLOGIES AND GLOBAL MARKET (REPORT HLC185A)

  • INTRODUCTION
    • STUDY BACKGROUND
    • GOALS AND OBJECTIVES
    • INTENDED AUDIENCE
    • SCOPE AND FORMAT
    • METHODOLOGY
    • ANALYSTS' CREDENTIALS
    • RELATED BCC RESEARCH REPORTS
  • EXECUTIVE SUMMARY
    • TABLE 26 GLOBAL MARKET FOR SELECTED HEALTH SELF-MONITORING TECHNOLOGIES, THROUGH 2019 ($ MILLIONS)
    • FIGURE 29 GLOBAL MARKET FOR SELECTED HEALTH SELF-MONITORING TECHNOLOGIES, 2013-2019 ($ MILLIONS)
  • DEFINITIONS
    • DIGITAL VS. ANALOG MONITORING TECHNOLOGIES
    • MOBILE VS. PORTABLE MONITORING TECHNOLOGIES
    • SELF-TESTING VS. SELF-MONITORING
    • HEALTH VS. SPORTS AND FITNESS MONITORING
  • ENABLING TECHNOLOGIES
    • SMARTPHONES
    • ENHANCED DATA PROCESSING CAPABILITIES
    • SENSORS
      • MEMS Sensors
      • PFOE Sensors
    • GEOSPATIAL TRACKING
    • SMART TEXTILES FOR WEARABLE SENSORS
    • NETWORKING TECHNOLOGIES
      • Bluetooth
      • ANT+
      • ZigBee
      • Near-Field Communications
      • Human Area Networks
      • Cellular Communications
      • Wi-Fi
    • CLOUD SERVICES
  • MARKET SEGMENTS
    • TECHNOLOGIES
      • Platforms
      • Hubs
        • FIGURE 30 SELF-MONITORING HUB (SCHEMATIC)
      • Peripherals
      • Software
    • APPLICATIONS
      • Fitness, Wellness and Prevention
      • Fertility and Reproductive Health
      • Chronic Disease Management
      • Post-Acute Care and Rehabilitation
      • Aging at Home
      • Mental Health
    • PURCHASERS/PAYERS
      • Consumers
      • Employers
      • Hospitals/Healthcare Providers
      • Insurers
      • Private Insurers
      • Medicare and Medicaid
    • MARKET SUMMARY
      • FIGURE 31 GLOBAL MARKET FOR HEALTH SELF-MONITORING TECHNOLOGIES, 2013-2019 ($ MILLIONS)
      • TABLE 27 GLOBAL MARKET FOR HEALTH SELF-MONITORING TECHNOLOGIES BY TYPE OF TECHNOLOGY, THROUGH 2019 ($ MILLIONS)
      • FIGURE 32 GLOBAL MARKET FOR HEALTH SELF-MONITORING TECHNOLOGIES BY REGION, 2013-2019 ($ MILLIONS)

CHAPTER 7 - OPHTHALMIC DEVICES: TECHNOLOGIES AND GLOBAL MARKETS (REPORT HLC173A)

  • INTRODUCTION
    • STUDY GOALS AND OBJECTIVES
    • REASONS FOR DOING THE REPORT
    • SCOPE OF REPORT
    • INTENDED AUDIENCE
    • METHODOLOGY AND INFORMATION SOURCES
    • ANALYSTS' CREDENTIALS
    • RELATED BCC RESEARCH REPORTS
  • SUMMARY
    • TABLE 28 GLOBAL OPHTHALMIC DEVICE MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
    • FIGURE 33 GLOBAL OPHTHALMIC DEVICE MARKET BY REGION, 2013-2019 ($ MILLIONS)
  • INTRODUCTION TO THE HUMAN EYE
    • FIGURE 34 STRUCTURE OF THE EYE
  • EYE CONDITIONS AND THE ADDRESSABLE POPULATION
    • CATARACTS
      • Cataract Prevalence
        • FIGURE 35 PREVALENCE OF CATARACTS IN THE UNITED STATES, 2000-2050 (MILLIONS)
      • Cataract Treatment
    • GLAUCOMA
      • Prevalence of Glaucoma
        • FIGURE 36 PREVALENCE OF GLAUCOMA IN THE UNITED STATES, 2000-2050 (MILLIONS)
      • Treatment and Monitoring
      • New Surgical Glaucoma Treatments
    • DIABETIC RETINOPATHY
      • Prevalence of Diabetic Retinopathy
        • TABLE 29 PREVALENCE OF DIABETIC RETINOPATHY BY REGION (%)
      • Treatment and Monitoring
    • AGE-RELATED MACULAR DEGENERATION
      • Prevalence of AMD
        • FIGURE 37 PREVALENCE OF AGE-RELATED MACULAR DEGENERATION IN THE UNITED STATES, 2000-2050 (MILLIONS)
      • Diagnosis and Treatment of AMD
    • REFRACTIVE DISORDERS
      • Prevalence of Refractive Disorders
        • FIGURE 38 PREVALENCE OF MYOPIA AND HYPEROPIC IN THE UNITED STATES, 2000-2050 (MILLIONS)
      • Diagnosis and Treatment of Refractive Disorders

LIST OF TABLES

  • TABLE 1: MARKET FOR U.S. LABORATORY-DEVELOPED TESTS, THROUGH 2019 ($ MILLIONS)
  • TABLE 2: LIFE CYCLE OF CLINICAL DIAGNOSTIC TESTS
  • TABLE 3: RADIATION THERAPY MARKET BY TYPE, THROUGH 2019 ($ MILLIONS)
  • TABLE 4: CHARACTERISTICS OF BENIGN AND MALIGNANT TUMORS
  • TABLE 5: IMPACT OF CANCER PROTECTIVE FACTORS AND CANCER RISK FACTORS ON VARIOUS TYPES OF CANCERS
  • TABLE 6: STEPS INVOLVED IN RADIATION THERAPY
  • TABLE 7: ADVANTAGES AND DISADVANTAGES OF VARIOUS CANCER TREATMENTS
  • TABLE 8: GLOBAL MARKET FOR MIS DEVICES AND EQUIPMENT, THROUGH 2019 ($ MILLIONS)
  • TABLE 9: SURGICAL PROCEDURES COMMONLY PERFORMED IN THE U.S. USING A MINIMALLY INVASIVE APPROACH, 2013
  • TABLE 10: PRINCIPAL TYPES OF MONITORING/VISUALIZATION EQUIPMENT
  • TABLE 11: PRINCIPAL TYPES OF SURGICAL ROBOTIC SYSTEMS
  • TABLE 12: ELECTROSURGICAL EQUIPMENT
  • TABLE 13: PRINCIPAL TYPES OF MECHANICAL INSTRUMENTS
  • TABLE 14: PRINCIPAL TYPES OF AUXILIARY EQUIPMENT USED FOR MINIMALLY INVASIVE SURGERY
  • TABLE 15: MINIMALLY INVASIVE SURGICAL DEVICES
  • TABLE 16: GLOBAL MARKET FOR DISPOSABLE MEDICAL SENSORS BY REGION, THROUGH 2019 ($ MILLIONS)
  • TABLE 17: EVOLUTION OF MEMS IN THE HEALTHCARE SECTOR
  • TABLE 18: CANCER INCIDENCES, 2008 AND 2015 (MILLIONS)
  • TABLE 19: NORTH AMERICA DIABETES PREVALENCE BY COUNTRY, 2013 AND 2035 (%)
  • TABLE 20: EUROPEAN DIABETES PREVALENCE BY COUNTRY, 2013 AND 2035 (%)
  • TABLE 21: ASIA-PACIFIC DIABETES PREVALENCE BY COUNTRY, 2013 AND 2035 (%)
  • TABLE 22: LATIN AMERICAN DIABETES PREVALENCE BY COUNTRY, 2013 AND 2035 (%)
  • TABLE 23: MENA DIABETES PREVALENCE BY COUNTRY, 2013 AND 2035 (%)
  • TABLE 24: CIS DIABETES PREVALENCE BY COUNTRY, 2013 AND 2035 (%)
  • TABLE 25: IMPLANTABLE SENSORS
  • TABLE 26: GLOBAL MARKET FOR SELECTED HEALTH SELF-MONITORING TECHNOLOGIES, THROUGH 2019 ($ MILLIONS)
  • TABLE 27: GLOBAL MARKET FOR HEALTH SELF-MONITORING TECHNOLOGIES BY TYPE OF TECHNOLOGY, THROUGH 2019 ($ MILLIONS)
  • TABLE 28: GLOBAL OPHTHALMIC DEVICE MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
  • TABLE 29: PREVALENCE OF DIABETIC RETINOPATHY BY REGION (%)

LIST OF FIGURES

  • FIGURE 1: MARKET FOR U.S. LABORATORY-DEVELOPED TESTS, 2012-2019 ($ MILLIONS)
  • FIGURE 2: RADIATION THERAPY MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
  • FIGURE 3: TYPES OF RADIATION
  • FIGURE 4: CELL GROWTH CYCLE
  • FIGURE 5: RADIATION THERAPY MARKET SEGMENTATION
  • FIGURE 6: DRIVERS, RESTRAINTS, OPPORTUNITIES AND TRENDS IN THE RADIATION THERAPY MARKET
  • FIGURE 7: GLOBAL AGING POPULATION (MILLIONS)
  • FIGURE 8: FACTORS RELATED TO AGING AND THE PROMOTION OF CANCER
  • FIGURE 9: MARKET SHARE ANALYSIS OF THE RADIATION THERAPY MARKET, 2013 (%)
  • FIGURE 10: GLOBAL MARKET FOR MIS DEVICES AND EQUIPMENT, 2013-2019 ($ MILLIONS)
  • FIGURE 11: MIS PROCEDURES AS A PERCENTAGE OF ALL SURGICAL PROCEDURES PERFORMED IN THE U.S., 2013 (%)
  • FIGURE 12: MIS PROCEDURES AS A PERCENTAGE OF SELECTED TYPES OF SURGICAL MEASURES IN THE U.S., 2013
  • FIGURE 13: SURGICAL PROCEDURES PERFORMED IN THE U.S. USING ALL MIS APPROACHES, 2013 (% OF ALL MIS PROCEDURES)
  • FIGURE 14: U.S. HOSPITALS WITH SURGERY DEPARTMENTS, 2013 (NUMBER OF HOSPITALS)
  • FIGURE 15: U.S. SURGICAL SPECIALTIES, 2013 (% OF ALL U.S. SURGEONS)
  • FIGURE 16: GLOBAL MARKET FOR DISPOSABLE MEDICAL SENSORS BY REGION, 2013-2019 ($ MILLIONS)
  • FIGURE 17: TYPES OF SENSORS
  • FIGURE 18: SEGMENTATION OF BIOSENSORS
  • FIGURE 19: GLOBAL MARKET FOR DISPOSABLE MEDICAL SENSORS BY PRODUCT, 2013 ($ MILLIONS)
  • FIGURE 20: GLOBAL MARKET FOR DISPOSABLE MEDICAL SENSORS BY TYPE, 2013 ($ MILLIONS)
  • FIGURE 21: GLOBAL MARKET FOR DISPOSABLE MEDICAL SENSORS BY APPLICATION, 2013 ($ MILLIONS)
  • FIGURE 22: GLOBAL MARKET FOR DISPOSABLE MEDICAL SENSORS BY REGION, 2013-2019 ($ MILLIONS)
  • FIGURE 23: DIABETES PREVALENCE IN TOP 10 COUNTRIES FOR AGES 20 TO 79 YEARS, 2013 (MILLIONS)
  • FIGURE 24: GLOBAL DIABETES PREVALENCE BY REGION, 2013 AND 2035 (MILLIONS)
  • FIGURE 25: ESTIMATED PERCENTAGE INCREASE IN NUMBER OF PERSONS (65 YEARS AND OLDER) WITH HEARING LOSS BY REGION, 2010-2020 (%)
  • FIGURE 26: GLOBAL PERCENTAGE A PERSON'S SUSCEPTIBILITY TO CHRONIC DISEASES BY AGE GROUP, 2000 AND 2015 (%)
  • FIGURE 27: GLOBAL MARKET SHARE FOR DISPOSABLE MEDICAL SENSORS BY COMPANY, 2013* (%)
  • FIGURE 28: APPROVAL PROCESS OF CHINA SFDA REGULATORY BODY INVOLVED IN DISPOSABLE MEDICAL SENSORS
  • FIGURE 29: GLOBAL MARKET FOR SELECTED HEALTH SELF-MONITORING TECHNOLOGIES, 2013-2019 ($ MILLIONS)
  • FIGURE 30: SELF-MONITORING HUB (SCHEMATIC)
  • FIGURE 31: GLOBAL MARKET FOR HEALTH SELF-MONITORING TECHNOLOGIES, 2013-2019 ($ MILLIONS)
  • FIGURE 32: GLOBAL MARKET FOR HEALTH SELF-MONITORING TECHNOLOGIES BY REGION, 2013-2019 ($ MILLIONS)
  • FIGURE 33: GLOBAL OPHTHALMIC DEVICE MARKET BY REGION, 2013-2019 ($ MILLIONS)
  • FIGURE 34: STRUCTURE OF THE EYE
  • FIGURE 35: PREVALENCE OF CATARACTS IN THE UNITED STATES, 2000-2050 (MILLIONS)
  • FIGURE 36: PREVALENCE OF GLAUCOMA IN THE UNITED STATES, 2000-2050 (MILLIONS)
  • FIGURE 37: PREVALENCE OF AGE-RELATED MACULAR DEGENERATION IN THE UNITED STATES, 2000-2050 (MILLIONS)
  • FIGURE 38: PREVALENCE OF MYOPIA AND HYPEROPIC IN THE UNITED STATES, 2000-2050 (MILLIONS)
Back to Top